Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Shares Outstanding (Weighted Average) (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $40.5 million as the latest value for Q3 2021.

  • Quarterly Shares Outstanding (Weighted Average) rose 69.41% to $40.5 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $40.5 million through Sep 2021, up 69.41% year-over-year, with the annual reading at $19.2 million for FY2020, 155.9% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2021 was $40.5 million at ENDRA Life Sciences, down from $41.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $41.7 million in Q2 2021, with the low at $723335.0 in Q1 2017.
  • Average Shares Outstanding (Weighted Average) over 5 years is $12.8 million, with a median of $7.4 million recorded in 2019.
  • The sharpest move saw Shares Outstanding (Weighted Average) changed 0.0% in 2017, then soared 442.35% in 2018.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $2.8 million in 2017, then skyrocketed by 63.4% to $4.5 million in 2018, then skyrocketed by 66.49% to $7.5 million in 2019, then surged by 155.9% to $19.2 million in 2020, then soared by 110.88% to $40.5 million in 2021.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $40.5 million, $41.7 million, and $37.8 million for Q3 2021, Q2 2021, and Q1 2021 respectively.